8,456 peer-reviewed studies, each with a short note written from its published abstract: what kind of study it was, who took part, what was measured and what the authors reported. Observational studies show associations, not proof.
An expert overview of the literature, useful as background reading.
2014 / Bibliometric analysis of randomized controlled trials
This bibliometric analysis evaluated the characteristics of yoga RCTs published between 1975 and February 2014. A total of 366 papers reporting 312 RCTs with 22,548 participants were included, with a median sample size of 59. Adults were studied in 84.6% of RCTs, older adults in 33.7%, and healthy participants in 26.9%; common medical conditions included breast cancer (5.4%), depression (4.5%), asthma (4.5%), and type 2 diabetes mellitus (4.2%). Interventions had a median duration of 9 weeks, with 78.2% using postures and 74.4% using breath control, while 55.6% compared yoga to no specific treatment.
Cramer H, Lauche R, Dobos G BMC Complement Altern Med, 2014. PMID 25183419
2014 / Narrative review
This review summarizes evidence from recent human and animal studies on the health benefits and commercial applications of flaxseed. Flaxseed is rich in α-linolenic acid, lignans, fiber, and protein. These components are linked to potential benefits in reducing cardiovascular disease, atherosclerosis, diabetes, cancer, arthritis, osteoporosis, and autoimmune and neurological disorders.
Goyal A, Sharma V, Upadhyay N, et al. J Food Sci Technol, 2014. PMID 25190822
2014 / Narrative review
This review evaluated the translational pathway of circadian rhythm research from animal models to human jet lag interventions. The authors argue that translation to effective treatments and long-term health is not robust, noting that the circadian disruption-cancer link in animals does not translate well to flight crew, who have lower risks for most cancers. Although animal studies grew exponentially from 1990 to 2014, only 1-2 randomized controlled trials on jet lag treatments appear annually. A relevant Cochrane review meta-analyzed only 2-4 melatonin studies without baseline measures, and study effect sizes for melatonin decreased substantially between 1987 and 2000.
Atkinson G, Batterham AM, Dowdall N, et al. Eur J Appl Physiol, 2014. PMID 25342081
2014 / Narrative review
This review discusses the link between diabetes mellitus, particularly type 2 diabetes, and cancer. Cancers including pancreatic, liver, breast, and female reproductive cancers display higher prevalence and mortality in diabetic patients compared to healthy subjects. Potential drivers of increased tumor growth include hyperinsulinemia, chronic inflammation, and hyperglycemia, though exact molecular mechanisms remain incompletely understood.
Shows an association, not proof of cause and effect.
Ryu TY, Park J, Scherer PE Diabetes Metab J, 2014. PMID 25349819
2014 / Narrative review
This review examines evidence connecting nutrition, lifestyle, and prostate cancer development. Obesity, metabolic syndrome, and high intake of saturated and trans fats are identified as negative factors related to prostate cancer risk. Conversely, nutraceuticals and supplements such as antioxidants, polyphenols, and soy have evidence of benefit for prevention and progression.
Shows an association, not proof of cause and effect.
Patel VH Expert Rev Anticancer Ther, 2014. PMID 25367323
2014 / Review of pooled/meta-analyses and systematic reviews
This review synthesized 304 pooled/meta-analyses and systematic reviews published between 1950 and 2013 examining associations between 17 food/beverage groups and 10 diet-related chronic diseases (DRCDs). Plant food groups were found to be more protective than animal food groups, with grain products being more protective than fruits and vegetables. Dairy/milk products showed a neutral effect, while red/processed meats tended to increase risk; tea was the most protective beverage and soft drinks the least. Overweight/obesity, type 2 diabetes, cardiovascular diseases, and cancers accounted for 289 of the reviews, while no reviews were identified for sarcopenia or kidney disease.
Shows an association, not proof of cause and effect.
Fardet A, Boirie Y Nutr Rev, 2014. PMID 25406801
2014 / Narrative review / hypothesis paper
Statistics indicate that mortality from chronic obstructive pulmonary disease (COPD) and lung cancer is lowest in Hispanic individuals compared to other racial and ethnic groups, an observation known as the 'Hispanic paradox.' This review hypothesizes that traditionally high legume intake (beans and lentils) among Hispanic subjects may partly explain this paradox. Legumes are rich in fiber and attenuate systemic inflammation, which is linked to susceptibility to these diseases. The authors state this hypothesis requires confirmation in prospective cohort studies and randomized controlled trials.
Shows an association, not proof of cause and effect.
Young RP, Hopkins RJ Eur Respir Rev, 2014. PMID 25445942
2014 / Narrative review
This review discusses the historical perspective and current understanding of vitamin D in human physiology and pathology. It highlights key milestones including vitamin D curing rickets, the characterization of its photoproduction and receptor interactions, and findings from large epidemiological studies suggesting optimal serum levels protect against multiple diseases including cancer. The authors note that while vitamin D is not a cure-all, alternative metabolic pathways offer promising avenues for disease prophylaxis and treatment.
Wierzbicka J, Piotrowska A, Żmijewski MA Acta Biochim Pol, 2014. PMID 25566549
2013 / Narrative review
This review evaluated the effects of antioxidants during oncology treatments and discussed their possible events and efficacy. Many chemotherapy drugs and radiotherapy rely on generating reactive oxygen species, which are also often a source of serious side effects. The authors note debate persists regarding whether antioxidant supplementation alters the efficacy of cancer chemotherapy. Evidence remains limited in both quality and sample size, suggesting certain antioxidant supplements may reduce adverse reactions and toxicities, which might help patients complete prescribed regimens.
Fuchs-Tarlovsky V Nutrition, 2013. PMID 22784609
2013 / Narrative review
This review discusses the vascular effects of dietary nitrate from vegetables such as green leafy vegetables and beetroot through the nitrate-nitrite-nitric oxide pathway. Dietary nitrate has been shown to reduce blood pressure, inhibit platelet aggregation, preserve or improve endothelial dysfunction, and enhance exercise performance in healthy individuals and patients with peripheral arterial disease. Epidemiological studies suggest reduced cardiovascular risk with nitrate-rich vegetable diets, though associations with cancer remain unproven. A major limitation is the lack of data concerning the long-term effects of dietary nitrate.
Lidder S, Webb AJ Br J Clin Pharmacol, 2013. PMID 22882425
2013 / Narrative review
This review examines the chemical constituents, biological activities, molecular targets, and clinical potential of turmeric. Curcumin constitutes 2-5% of turmeric, though some activities of turmeric are curcumin-independent. Clinical trials have demonstrated the efficacy of turmeric against human ailments including lupus nephritis, cancer, diabetes, irritable bowel syndrome, acne, and fibrosis.
Gupta SC, Sung B, Kim JH, et al. Mol Nutr Food Res, 2013. PMID 22887802
2013 / Narrative review
This review examines the extensive research surrounding vitamin D status and health outcomes. While adequate vitamin D status has been linked to reduced risks of multiple cancers, infections, cardiovascular diseases, diabetes, and other conditions, the author suggests enthusiasm may be excessively optimistic. The review highlights that serum 25-OHD(3) can be poorly responsive to intake, local tissue intoxication may occur at lower serum levels than recognized, and prolonged consumption of thousands of international units of vitamin D may interfere with phosphate homeostasis regulated by FGF23 and Klotho.
Glade MJ Nutrition, 2013. PMID 23085014
2013 / Narrative review of clinical trials
This review examines clinical trials from the past quarter century addressing the pharmacokinetics, safety, and efficacy of curcumin in humans. Promising effects were noted in patients with diverse pro-inflammatory diseases, such as cancer, cardiovascular disease, arthritis, gastrointestinal conditions, diabetes, and renal diseases. Dose-escalating studies showed curcumin is safe at doses as high as 12 g/day over 3 months. Curcumin modulates numerous human signaling molecules, including pro-inflammatory cytokines, apoptotic proteins, NF-κB, COX-2, STAT3, C-reactive protein, and triglycerides.
Gupta SC, Patchva S, Aggarwal BB AAPS J, 2013. PMID 23143785
2013 / Review of a prospective controlled intervention trial
This article reviews key results published between 2004 and 2012 from the Swedish Obese Subjects study, comparing 2,010 bariatric surgery patients with 2,037 matched controls over 10 to 20 years. Mean weight changes after 2, 10, 15, and 20 years were -23%, -17%, -16%, and -18% in the surgery group versus 0%, 1%, -1%, and -1% in controls. Compared with usual care, surgery was associated with lower overall mortality (adjusted HR = 0.71, 95% CI 0.54-0.92) and decreased incidences of diabetes (adjusted HR = 0.17), myocardial infarction (adjusted HR = 0.71), stroke (adjusted HR = 0.66), and cancer in women (adjusted HR = 0.58). Baseline insulin and glucose, but not baseline BMI, predicted favorable treatment effects.
Shows an association, not proof of cause and effect.
Sjöström L J Intern Med, 2013. PMID 23163728
2013 / Narrative review
This review examines the mechanisms of curcumin, an active constituent of turmeric, in cancer prevention and treatment across various cancers. Curcumin modulates cell signaling pathways by interacting with transcription factors, growth factors, enzymes, kinases, and inflammatory cytokines, while upregulating proapoptotic and downregulating antiapoptotic proteins. Animal models and human studies have indicated that curcumin is safe and well tolerated even at very high doses.
Shehzad A, Lee J, Lee YS Biofactors, 2013. PMID 23303705
2013 / Narrative review
This review evaluates the pharmaceutical uses of curcumin, an active polyphenol found in turmeric. More than 65 human clinical trials including over 1,000 patients have been completed, with as many as 35 clinical trials underway. Preclinical and clinical research indicates curcumin targets multiple signaling pathways and chronic conditions, including cancer, cardiovascular, metabolic, pulmonary, neurological, autoimmune, and liver diseases.
Gupta SC, Kismali G, Aggarwal BB Biofactors, 2013. PMID 23339055
2013 / Narrative review
This review presents highlighted evidence on the link between pesticide exposure and chronic diseases. The authors report evidence associating pesticide exposure with elevated rates of cancers, diabetes, neurodegenerative disorders (Parkinson, Alzheimer, ALS), birth defects, and reproductive disorders, alongside circumstantial links to respiratory, cardiovascular, nephropathic, and autoimmune diseases. Proposed mechanisms include disturbance in cellular homeostasis via ion channel and enzyme perturbation, genetic damage, epigenetic changes, endocrine disruption, mitochondrial dysfunction, oxidative stress, endoplasmic reticulum stress, and defective autophagy.
Shows an association, not proof of cause and effect.
Mostafalou S, Abdollahi M Toxicol Appl Pharmacol, 2013. PMID 23402800
2013 / Narrative review
This review examines evidence on the discordance between modern and ancestral diets as a driver of rising chronic disease, as well as evidence supporting plant food consumption to reduce chronic disease risk. It reviews mechanisms of phytonutrients and considerations for avoiding certain plant food components enriched in Western diets. The reviewed evidence suggests that consuming more fruits and vegetables could aid in the prevention and medical nutrition therapy of conditions such as type 2 diabetes, heart disease, cancer, and obesity.
Martin C, Zhang Y, Tonelli C, et al. Annu Rev Plant Biol, 2013. PMID 23451785
2013 / Review of epidemiological and microbiological studies (2008-2012)
Researchers reviewed recent epidemiological studies and microbiological research published between 2008 and 2012 regarding isoflavone intake, equol-producing flora, and prostate cancer (PCa) risk. Five out of six articles showed a significant association of isoflavones with a decreased risk of PCa, and two of these consistently reported that equol-producers have a significantly reduced risk. Additionally, five human intestinal bacteria capable of converting daidzein into equol were identified within the evaluated timeframe.
Shows an association, not proof of cause and effect.
Sugiyama Y, Masumori N, Fukuta F, et al. Asian Pac J Cancer Prev, 2013. PMID 23534704
2013 / Review of RCTs, meta-analyses, and other evidence
This review examined randomized controlled trials, meta-analyses, and other evidence concerning vitamin D actions across multiple health outcomes. Adequate vitamin D status seems to protect against musculoskeletal disorders, infectious diseases, autoimmune diseases, cardiovascular disease, type 1 and type 2 diabetes mellitus, several cancers, neurocognitive dysfunction, mental illness, infertility, and adverse pregnancy/birth outcomes. Vitamin D deficiency and insufficiency were associated with all-cause mortality.
Pludowski P, Holick MF, Pilz S, et al. Autoimmun Rev, 2013. PMID 23542507
2013 / Narrative review
This review examines the pharmacology, efficacy, adverse effects, and dosage of curcuminoids and standardized curcumin extracts. Early human clinical trials suggest potential beneficial effects for conditions such as dyspepsia, peptic ulcer, inflammatory bowel disease, rheumatoid arthritis, osteoarthritis, uveitis, orbital pseudotumor, and pancreatic cancer. Curcumin is generally well-tolerated, with nausea and diarrhea being the most common side effects. The authors note that late-phase clinical trials are still required to confirm most beneficial effects.
Asher GN, Spelman K Altern Ther Health Med, 2013. PMID 23594449
2013 / Narrative review
This review evaluates the pharmacokinetic rationale for reassessing ascorbate in cancer treatment. Tight control of tissue and plasma levels limits oral ascorbate, whereas intravenous administration bypasses this control. High-dose ascorbate generates extracellular hydrogen peroxide and exhibits selective cytotoxicity in cell lines and murine xenografts. Although pilot clinical studies have verified the safety of intravenous ascorbate, questions regarding its clinical efficacy remain.
Parrow NL, Leshin JA, Levine M Antioxid Redox Signal, 2013. PMID 23621620
2013 / Commentary / narrative review
This commentary discusses the potential of inflammatory biomarkers in cancer risk prediction and disease progression. Morris and colleagues reported that urinary PGE-M was positively associated with obesity, smoking, and lung metastases in breast cancer patients. Additionally, Kim and colleagues identified a potential association between urinary PGE-M and breast cancer risk among postmenopausal women, supporting urinary PGE-M as a promising biomarker.
Shows an association, not proof of cause and effect.
Wang D, DuBois RN Cancer Prev Res (Phila), 2013. PMID 23636051
2013 / Narrative review
This review discusses the nutritional aspects of dietary nitrate and nitrite and their implications for human health. Vegetables serve as the major dietary source of nitrate that fuels the nitrate-nitrite-nitric oxide (NO) pathway. While historically studied regarding cancer and nitrosamine formation, emerging research explores potential beneficial roles of these anions in physiology, nutrition, and therapeutics via recycling back to bioactive NO.
Weitzberg E, Lundberg JO Annu Rev Nutr, 2013. PMID 23642194